|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.38 USD | -1.29% |
|
-6.91% | +10.90% |
| Capitalization | 295.52Cr 253.91Cr 232.32Cr 220.63Cr 406.24Cr 28TCr 413.16Cr 2.78TCr 1.08TCr 13TCr 1.11TCr 1.09TCr 47TCr | P/E ratio 2026 * |
-7.62x | P/E ratio 2027 * | -7.64x |
|---|---|---|---|---|---|
| Enterprise value | 228.17Cr 196.05Cr 179.37Cr 170.35Cr 313.66Cr 22TCr 319.01Cr 2.15TCr 832.07Cr 10TCr 856.33Cr 838.19Cr 36TCr | EV / Sales 2026 * |
54.7x | EV / Sales 2027 * | 20.4x |
| Free-Float |
90.24% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Denali Therapeutics Inc.
| 1 day | -1.26% | ||
| 1 week | -6.91% | ||
| Current month | -2.19% | ||
| 1 month | -10.86% | ||
| 3 months | -4.78% | ||
| 6 months | +4.75% | ||
| Current year | +10.90% |
| 1 week | 18.23 |  | 20 |
| 1 month | 18.1 | | 20.88 |
| Current year | 15.34 | | 23.77 |
| 1 year | 12.58 | | 23.77 |
| 3 years | 10.57 | | 33.33 |
| 5 years | 10.57 | | 79.7 |
| 10 years | 10.57 | | 93.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Schuth
DFI | Director of Finance/CFO | 52 | 01/05/2022 |
Ryan Watts
CEO | Chief Executive Officer | 50 | 01/08/2015 |
Peter Chin
CTO | Chief Tech/Sci/R&D Officer | - | 06/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryan Watts
BRD | Director/Board Member | 50 | 01/03/2015 |
| Chairman | 66 | 01/03/2015 | |
Jay Flatley
BRD | Director/Board Member | 73 | 01/04/2015 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.29% | -6.91% | +31.63% | -39.67% | 295.52Cr | |
| -2.54% | -2.26% | +33.25% | +75.07% | 5.01TCr | |
| -1.05% | -4.45% | +66.31% | +50.52% | 4.58TCr | |
| -1.85% | +2.20% | +56.42% | +464.16% | 2.37TCr | |
| -1.31% | -5.72% | -10.02% | -16.15% | 2.26TCr | |
| -2.20% | +0.86% | +39.87% | -26.56% | 1.78TCr | |
| +0.39% | +1.90% | +28.07% | -41.95% | 1.61TCr | |
| -5.32% | -15.07% | +36.29% | +202.26% | 1.41TCr | |
| -6.70% | -16.18% | -34.86% | +865.46% | 1.31TCr | |
| -2.84% | -5.14% | +32.07% | - | 1.3TCr | |
| Average | -2.45% | -2.75% | +27.90% | +170.35% | 2.19TCr | |
| Weighted average by Cap. | -2.20% | -1.85% | +34.38% | +143.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.17Cr 3.59Cr 3.28Cr 3.12Cr 5.74Cr 401.99Cr 5.83Cr 39Cr 15Cr 190.2Cr 16Cr 15Cr 662.94Cr | 11Cr 9.77Cr 8.93Cr 8.49Cr 16Cr 1.09TCr 16Cr 106.94Cr 41Cr 518.03Cr 43Cr 42Cr 1.81TCr |
| Net income | -48Cr -42Cr -38Cr -36Cr -66Cr -4.66TCr -68Cr -455.04Cr -176.36Cr -2.2TCr -181.5Cr -177.66Cr -7.68TCr | -47Cr -40Cr -37Cr -35Cr -65Cr -4.54TCr -66Cr -443.41Cr -171.85Cr -2.15TCr -176.86Cr -173.11Cr -7.49TCr |
| Net Debt | -67Cr -58Cr -53Cr -50Cr -93Cr -6.49TCr -94Cr -633.67Cr -245.59Cr -3.07TCr -252.75Cr -247.4Cr -11TCr | -64Cr -55Cr -50Cr -48Cr -88Cr -6.17TCr -90Cr -602.95Cr -233.68Cr -2.92TCr -240.49Cr -235.4Cr -10TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | 18.28 $ | -1.83% | 10,53,359 |
| 15/26/15 | 18.62 $ | -3.97% | 21,54,160 |
| 14/26/14 | 19.39 $ | -2.07% | 18,28,149 |
| 13/26/13 | 19.80 $ | +1.75% | 12,57,933 |
| 12/26/12 | 19.46 $ | -1.07% | 17,92,302 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DNLI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition